Browsing Tag
Sandoz Group AG
2 posts
Avecho Biotechnology clears Phase III insomnia interim review as ASX:AVE surges 40%
Avecho Biotechnology’s CBD insomnia trial will continue with its original 519-patient design after an independent monitoring board found that predefined efficacy and safety requirements had been satisfied.
Avecho Biotechnology secures $19m+ deal with Sandoz for CBD insomnia treatment in Australia
Avecho Biotechnology Limited has entered an exclusive 10-year development and licensing agreement with Sandoz Group AG to commercialise…